APC Resistance

Activated protein-C is a protein (protein) from the blood clotting system. It is dependent on vitamin K.

APC resistance (synonym: factor V Leiden mutation (FVL mutation); note: V stands for the number five) is a mutation in a blood clotting factor, factor V, making it resistant to protein-C. This results in an increased tendency to thrombosis.

In the heterozygous form (= inherited from only one parent) of APC resistance, the risk of thrombosis is increased 5-10-fold. In the homozygous form (= inherited from both parents), the risk is 50-100-fold.

The procedure

Material needed

  • EDTA blood (a completely filled tube).

Preparation of the patient

  • Not necessary

Disruptive factors

  • Not known

Normal value

Rating APC Ratio
No evidence for a factor V mutation > 2,3
V.a. heterozygous form 1,5-2,3
V.a. homozygous form < 1,5

Ratio is determined by measuring PTT with/without addition of protein-C.

Indications

  • Suspicion of increased thrombotic tendency (thrombophilia screening).

Interpretation

Interpretation of increased values

  • Not relevant to disease

Interpretation of lowered values

  • Increased tendency to thrombosis

Other indications

  • Genetic analysis can be performed to confirm the suspected diagnosis. The cause is 95% a mutation in the factor V gene (factor V:R506Q).
  • For condition after thromboembolism: prolonged maintenance therapy is not recommended for heterozygous factor V Leiden mutation.